Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib + Chemotherapy in Pancreatic Cancer with Liver Metastases
NCT05168527Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Sep 2021
- Primary completion
- Mar 2024
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fruquintinib in pancreatic cancer (PC), sponsored by Fudan University. Status: unknown.
02
Drugs
fruquintinib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT05168527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05168527.